Mikka 250mg Injection
Marketer
Syndicate Overseas
Salt Composition
Amikacin (250mg)
Overview Mikka 250mg Injection
Cefamika 250mg Injection combats a broad spectrum of bacterial infections, offering prophylaxis and treatment for conditions affecting the urinary tract, musculoskeletal system (bones and joints), respiratory system (including pneumonia), central nervous system, and bloodstream. Hospitalized patients may also receive it for infection prevention. Its mechanism involves inhibiting bacterial growth. Administered intravenously (drip) or via intramuscular/intravenous injection by a healthcare professional only, it requires consistent dosing at prescribed intervals. Complete the entire course, even with symptom improvement, to prevent relapse. Premature discontinuation risks infection recurrence or exacerbation. Common adverse effects include injection site reactions and elevated blood urea nitrogen (BUN). Persistent side effects or treatment inefficacy necessitate consultation with your physician. High doses may rarely cause vertigo, nephrotoxicity, and ototoxicity. Adhere strictly to your doctor's instructions, potentially including regular kidney function, hearing, and urinalysis. This injection is contraindicated during pregnancy; inform your physician of pregnancy, pregnancy planning, or breastfeeding.
Uses of Mikka 250mg Injection
Infections caused by bacteria
Major Benefits of Mikka 250mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Mikka 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikka 250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Mikka 250mg Injection works:
The antibiotic injection, Mikka 250mg, inhibits bacterial proliferation by disrupting the production of vital proteins necessary for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Mikka 250mg Injection and alcohol does not produce adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Mikka 250mg Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. In exceptional, life-threatening circumstances, a physician might consider its use only if the potential benefits demonstrably outweigh the inherent dangers. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Mikka 250mg Injection while breastfeeding presents minimal risk. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent threat to the infant.
DrivingUNSAFE
Administering Mikka 250mg Injection might induce drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Caution is advised when administering Mikka 250mg Injection to individuals with impaired renal function. Dosage modification of Mikka 250mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Mikka 250mg Injection in individuals with liver impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary. Physician consultation is recommended.
What if you forget to take Mikka 250mg Injection :
Omit a Mikka 250mg Injection dose? Seek your physician's advice.
Facts to Know About Mikka 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Aminoglycoside antibiotics |
3,018 People bought this recently